Related Experiment Video

Updated: Oct 2, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

p14(ARF) nuclear overexpression in aggressive B-cell lymphomas is a sensor of malfunction of the common tumor

Abel Sánchez-Aguilera1, Margarita Sánchez-Beato, Juan F García

  • 1Molecular Pathology Program, Centro Nacional de Investigaciones Oncológicas Carlos III (CNIO), Madrid, Spain.

Blood
|February 7, 2002
PubMed

Insights

The p14(ARF) protein, crucial for cell cycle control, shows abnormal nuclear overexpression in aggressive B-cell lymphomas. This overexpression acts as a marker for malfunctioning cell cycle pathways and predicts a more aggressive clinical course.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • p14(ARF) antagonizes Hdm2 and activates p53 in response to oncogenic stress.
  • The INK4a/ARF locus is critical for tumor suppression.
  • Dysregulation of cell cycle regulators is a hallmark of aggressive cancers.

Purpose of the Study:

  • To investigate p14(ARF) expression patterns in aggressive B-cell lymphomas.
  • To correlate p14(ARF) abnormalities with molecular alterations and clinical behavior.
  • To determine if p14(ARF) overexpression serves as a prognostic marker.

Main Methods:

  • Immunohistochemistry to assess p14(ARF) expression in 74 lymphoma samples.
  • Confocal microscopy to confirm abnormal nuclear localization.
  • Genetic analysis to identify p14(ARF) and p53 gene alterations.
  • Correlation with p53, p16(INK4a), and p27(KIP1) alterations and clinical data.

Main Results:

  • p14(ARF) showed varied expression: nucleolar in 50/74, absent in 8/74 (due to hypermethylation/loss), and abnormal nuclear overexpression in 16/74.
  • Nuclear overexpression of p14(ARF) correlated with high p53 and Hdm2 levels, p53 mutations (>50% of these cases), increased growth fraction, and aggressive clinical course.
  • Abnormal p14(ARF) patterns were more frequent in tumors with accumulated alterations in p53, p16(INK4a), and p27(KIP1).

Conclusions:

  • Abnormal nuclear overexpression of p14(ARF) is associated with p53 pathway dysfunction and alterations in other key cell cycle regulators.
  • This aberrant p14(ARF) expression serves as a potential biomarker for aggressive B-cell lymphomas.
  • p14(ARF) nuclear overexpression indicates a breakdown in major cell cycle regulatory pathways, signifying high tumor aggressiveness.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are: